Clinical trial
Circulating Tumor DNA Predict Recurrence and Aid Treatment Decisions in Colon Cancer
NCT02997241 is registered in ClinicalTrials.gov with MyGenostics Inc., Beijing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circulating Tumor DNA Predict Recurrence and Aid Treatment Decisions in Colon Cancer
- Lead sponsor
- MyGenostics Inc., Beijing
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2017
- Completion date
- September 30, 2022
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.